Abbott to Pay $51 Per Share to Buy Alere in Amended Pact
Alert: HALISTER
Source: BFW (Bloomberg First Word)
Tickers
ALR US (Alere Inc)
ABT US (Abbott Laboratories)
To de-activate this alert, click here
To modify this alert, click here
UUID: 7947283
(Bloomberg) -- Abbott and Alere have agreed to amend their merger pact and dismiss their respective lawsuits, the companies said in a statement today.
- Abbott will pay $51 per common share to acquire Alere
- The new equity value of about $5.3b was cut from originally expected equity value of about $5.8b
- Under the amended terms, the date by which necessary regulatory approvals must be received has been extended to Sept. 30, from April 30
Alert: HALISTER
Source: BFW (Bloomberg First Word)
Tickers
ALR US (Alere Inc)
ABT US (Abbott Laboratories)
To de-activate this alert, click here
To modify this alert, click here
UUID: 7947283